Advertisement

Topics

PPI Use and Risk of Hepatic Encephalopathy in Cirrhotic Patients

10:26 EDT 23 Sep 2016 | Medscape

Patients with cirrhosis who are treated with a proton pump inhibitor (PPI) face an increased risk of hepatic encephalopathy, and the risk rises in a dose-dependent fashion, a large study from Taiwan has found.
Reuters Health Information

Original Article: PPI Use and Risk of Hepatic Encephalopathy in Cirrhotic Patients

NEXT ARTICLE

More From BioPortfolio on "PPI Use and Risk of Hepatic Encephalopathy in Cirrhotic Patients"

Quick Search
Advertisement
 

Relevant Topic

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...